One of the listed companies, Advent Pharma Limited. discloses its financial reports for the third quarter, (January – March 24).
The company’s earnings per share (EPS) was Tk 0.29 paisa in Q3 of the current financial year (January – March 24). EPS was Tk 0.28 paisa during the same period last year. NAV per share was Tk. 15.79 on March 31, 2024
Share this
